# BEATcc (NCT03556839)

> Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03556839
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Grupo Español de Investigación en Cáncer de Ovario
- Conditions: Carcinoma of the Cervix, Stage IVB
- Interventions: Atezolizumab; Bevacizumab; Cisplatin/Carboplatin; Paclitaxel
- Enrollment: 410
- Primary outcome: Progression-free survival
- Primary outcome: Overall survival

## Commentary we found

- X threads: 5
- YouTube: 3
- Podcasts: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=beatcc-nct03556839

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03556839", "email": "<work email>"}; the inbox owner confirms by the emailed link.